Modeling and Analysis of Acute Leukemia using Human Hematopoietic Stem and Progenitor Cells

Modeling and Analysis of Acute Leukemia using Human Hematopoietic Stem and Progenitor Cells

Bibliographic Details
Main Author:	Lin, Shan
Language:	English
Published:	University of Cincinnati / OhioLINK 2016
Subjects:	Biology acute leukemia MLL-AF4 AML1-ETO FOXO1 human
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1481032144780412

Similar Items

CDK6 Inhibition: A Novel Approach in AML Management
by: Iris Z. Uras, et al.
Published: (2020-04-01)

The role of TLE4 as a tumor suppressor in acute myeloid leukemia and regulator of hematopoietic and bone development
by: Shin, Thomas H.
Published: (2017)

RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
by: Emiel van der Kouwe, et al.
Published: (2019-01-01)

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
by: Krzysztof Brzezinka, et al.
Published: (2019-06-01)

KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
by: Shanmin Zhao, et al.
Published: (2014-01-01)

Geographic Heterogeneity of the AML1-ETO Fusion Gene in Iranian Patients with Acute Myeloid Leukemia
by: Saeedeh Ghazaey Zidanloo, et al.
Published: (2014-10-01)

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
by: Xiaoyan Chen, et al.
Published: (2021-08-01)

Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein
by: Jiang Cao, et al.
Published: (2016-11-01)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
by: Caixia Han, et al.
Published: (2021-04-01)

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells
by: Valentina Rosso, et al.
Published: (2019-07-01)

Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia
by: Jialei Qi, et al.
Published: (2019-09-01)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
by: Alexia Tsakaneli, et al.
Published: (2021-09-01)

HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
by: Satoshi Takahashi, et al.
Published: (2021-08-01)

Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4–MLL Fusion Protein
by: Samaneh Sabiani, et al.
Published: (2015-05-01)

Gen de fusión AML1-ETO: particularidades en la leucemia mieloide aguda
by: Heidys Garrote Santana, et al.

Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
by: Yanan Gao, et al.
Published: (2016-04-01)

circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
by: Wei Huang, et al.
Published: (2019-10-01)

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
by: Mina Noura, et al.
Published: (2020-08-01)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
by: Mu G, et al.
Published: (2020-02-01)

IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
by: Y.C. Castro, et al.
Published: (2020-07-01)

Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia
by: Hélène Jakobczyk, et al.
Published: (2021-03-01)

Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cells
by: Farnaz eFaridi, et al.
Published: (2013-11-01)

Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
by: Sri Mulatsih, et al.
Published: (2009-10-01)

<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
by: Oliver Britten, et al.
Published: (2019-10-01)

A Novel Platform to Test In Vivo Single Gene Dependencies in t(8,21) and t(15,17) AML Confirms Zeb2 as Leukemia Target
by: Giulia De Conti, et al.
Published: (2020-12-01)

Defining and Targeting Transcriptional Pathways in Leukemia Stem Cells
by: Puram, Rishi Venkata
Published: (2014)

MLL-AF4 fusion transcripts in Acute Lymphocytic Leukemia patientsin Children hospital of Tabriz
by: Amir Monfaredan, et al.
Published: (2014-08-01)

High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia
by: Priscilla Wander, et al.
Published: (2021-05-01)

The role of THPO/MPL signaling in AML1-ETO self-renewal
by: Griesinger, Andrea
Published: (2011)

Zebrafish Model of MLL-Rearranged Acute Myeloid Leukemia
by: Belt, Alex J
Published: (2018)

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
by: Daniel T. Johnson, et al.
Published: (2021-02-01)

Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells
by: Monica Nafria, et al.
Published: (2020-05-01)

Acute leukemia in early childhood
by: M. Emerenciano, et al.
Published: (2007-06-01)

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
by: Juliana M. Benito, et al.
Published: (2015-12-01)

Relation between Genomic DNA Breakpoints in MLL Gene and Treatment Outcome in Infants with Acute Leukemia
by: GA Tsaur, et al.
Published: (2016-01-01)

Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
by: Aditya Barve, et al.
Published: (2019-10-01)

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming
by: Sophie Kellaway, et al.
Published: (2020-12-01)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01)

RIP1 deletion or mutation attenuates the pathogenicity of MLL-AF9 leukemia stem cells
by: XU Zhaofeng, et al.
Published: (2019-10-01)

B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy
by: Giovanni Carulli, et al.
Published: (2012-09-01)